| Q39615532 | (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A compa |
| Q45982741 | A comparison of episodic memory deficits in neuropathologically-confirmed Dementia with Lewy bodies and Alzheimer's disease. |
| Q49070070 | CASE REPORT: Psychotic symptoms complicate the clinical differentiation of Parkinson's disease with major depressive disorder from dementia with Lewy bodies |
| Q47344957 | Can alzheimer's disease and dementias with Lewy bodies be distinguished clinically? |
| Q35113689 | Clinicopathological concordance of dementia diagnoses by community versus tertiary care clinicians |
| Q90377168 | Common age-related neuropathologies and yearly variability in cognition |
| Q36315947 | Comparing hippocampal atrophy in Alzheimer's dementia and dementia with lewy bodies. |
| Q74089880 | Definition of 'neuroleptic sensitivity' |
| Q57306397 | Dementia with Lewy bodies |
| Q80690619 | Dementia with Lewy bodies |
| Q35474145 | Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older |
| Q35029466 | Dementia with Lewy bodies: clinical characteristics and diagnostic criteria. |
| Q35029472 | Dementia with Lewy bodies: neuropathology |
| Q48469027 | EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study. |
| Q46001712 | Effects of acute tryptophan depletion on neuropsychological and motor function in Parkinson's disease. |
| Q35553096 | Essentials of the Proper Diagnoses of Mild Cognitive Impairment, Dementia, and Major Subtypes of Dementia |
| Q30533941 | Extrapyramidal signs by dementia severity in Alzheimer disease and dementia with Lewy bodies |
| Q48587961 | Frontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer's disease |
| Q48264359 | Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP. |
| Q47977064 | Hypochondriasis as an early manifestation of dementia with Lewy bodies: an autopsied case report |
| Q34566561 | Lewy bodies and dementia |
| Q48263978 | Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem |
| Q40795880 | Limbic lobe microvacuolation is minimal in Alzheimer's disease in the absence of concurrent Lewy body disease |
| Q38901561 | Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort |
| Q37954450 | Modeling the dementia epidemic. |
| Q30756562 | Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology |
| Q74245351 | Neuropathological correlates to clinically defined dementia with Lewy bodies |
| Q33637285 | PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders |
| Q48378397 | Predicting lewy body pathology in a community-based sample with clinical diagnosis of Alzheimer's disease |
| Q34138207 | The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease |
| Q22250951 | The differential diagnosis of Parkinson's disease |
| Q35136912 | The new Qualitative Scoring MMSE Pentagon Test (QSPT) as a valid screening tool between autopsy-confirmed dementia with Lewy bodies and Alzheimer's disease |
| Q26853347 | The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's disease |
| Q43164212 | The role of I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies. |
| Q34114062 | Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe |
| Q37139055 | Visual search in Dementia with Lewy Bodies and Alzheimer's disease |
| Q80027950 | [Hallucinations and dementia. Prevalence, clinical presentation and pathophysiology] |